A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men

    Elise A. Olsen, David A. Whiting, Wilma F. Bergfeld, Jeffrey S. Miller, Maria K. Hordinsky, Rita Wanser, Paul J. Zhang, Bruce Kohut
    Image of study
    TLDR New 5% minoxidil foam effectively promotes hair growth and is safe for use.
    This study tested the efficacy and safety of a new 5% minoxidil topical foam in men with androgenetic alopecia. The trial involved 352 men and lasted for 16 weeks, with 143 subjects continuing on an open-label phase to collect 52 weeks of safety information on 5% MTF. The results showed that the 5% MTF was effective in promoting hair growth and was well-tolerated by the participants. The study led to the approval of 5% MTF for over-the-counter use in 2006.
    View this study on linkinghub.elsevier.com →

    Cited in this study